Advertisement

Topics

Orion Genomics. Company Profile

02:44 EDT 23rd June 2018 | BioPortfolio

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic patterns of DNA methylation, also known as DNA's Second Code.We are currently identifying epigenetic biomarkers and employing them in the development of novel molecular diagnostic tests to find breast, lung, ovarian, colorectal and other common cancers. Additionally, we are discovering biomarkers that can aid in the selection of best therapies for cancer patients.
Orion Genomics is the Second Code company.

Location

4041 Forest Park Ave
Saint Louis
Missouri
63108
United States of America

Contact

Phone: 314-615-6977
Fax: 314-615-6975
Email: info@oriongenomics.com


News Articles [377 Associated News Articles listed on BioPortfolio]

Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Orion's origins a...

Orion Resource Partners Closes Orion Mine Finance II LP at $2.1 Billion

Fund II is the successor fund to Orion Mine Finance Fund I and Orion Mine Finance Fund I-A (together, "Fund I") and will continue Orion's Read more...

Orion has completed the sale of Orion Diagnostica business division

ORION CORPORATION         PRESS RELEASE                30 April 2018 at 12.15 p.m. Orion has completed the sale of Orion Diagnostica business division Orion C...

Orion to divest diagnostics business for up to $272M

An agreement was reached by Orion to sell its diagnostics business, Orion Diagnostica, to an Axcel Management-led investment  -More- 

Orion to investigate possible sale of Orion Diagnostica

ORION CORPORATION         STOCK EXCHANGE RELEASE   23 JANUARY 2018 at 12.20. p.m. EET          Orion to investigate possible sale of Orion Diagnostica Orion Cor...

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum. K2Biomedical will operate as Orion Biotechnology Poland,...Read More... The post M&As this week: O...

Orion Group Financial Statement documents 2017 and Corporate Governance Statement published

ORION CORPORATION           STOCK EXCHANGE RELEASE         26 FEBRUARY 2018 at 13.00 EET                       Orion Group Financ...

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

PubMed Articles [240 Associated PubMed Articles listed on BioPortfolio]

An Interface for Biomedical Big Data Processing on the Tianhe-2 Supercomputer.

Big data, cloud computing, and high-performance computing (HPC) are at the verge of convergence. Cloud computing is already playing an active part in big data processing with the help of big data fram...

Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study.

Increasing awareness of, and information about, overdose risk is an appropriate approach in risk reduction. e-Health technology in substance use disorders is an opportunity to support behavioral chang...

Room 604 - Ode to Orion.

Commentary on "Room 604 - Ode to Orion".

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perce...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Prospective Registry on User Experience With The Mapping System For Ablation Procedures

This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagon...

Companies [419 Associated Companies listed on BioPortfolio]

Orion Genomics.

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic ...

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutriti...

Orion Energy Systems, Inc.

Orion is leading the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactu...

Orion Health, Inc.

Orion Health™ is the leading Health Information Exchange (HIE) solution provider with expertise in clinical workflow and integration technology for the healthcare sector. Ori...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement m...

More Information about "Orion Genomics." on BioPortfolio

We have published hundreds of Orion Genomics. news stories on BioPortfolio along with dozens of Orion Genomics. Clinical Trials and PubMed Articles about Orion Genomics. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orion Genomics. Companies in our database. You can also find out about relevant Orion Genomics. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them. ...


Corporate Database Quicklinks



Searches Linking to this Company Record